NewAmsterdam Pharma Company N.V.
← Back to NAMS Overview

NewAmsterdam Pharma Company N.V. (NAMS)

Revenue & Top-Line Growth

Latest Revenue

$32K

Financial Fundamentals

NAMSQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2025-12-310.00B-90.8%-99.7%0.02B-50.6%
2025-09-300.00B-98.2%-98.8%0.04B+4.9%
2025-06-300.02B+542.9%+740.1%0.06B+762.1%
2025-03-310.00B-76.7%+112.6%0.05B+587.0%
2024-12-310.01B-56.1%+1490.5%0.05B+223.4%
2024-09-300.03B+1177.4%+889.8%0.03B+78.8%
2024-06-300.00B+62.7%+32.7%0.01B-65.2%
2024-03-310.00B+74.5%-83.8%0.01B-90.0%
2023-12-310.00B-72.7%-85.4%0.01B-87.4%
2023-09-300.00B+71.3%-46.6%0.02B-82.3%
2023-06-300.00B-80.1%-96.5%0.02B-78.8%
2023-03-310.01B+56.8%-83.3%0.07B+32.7%
2022-12-310.01B0.0%0.11B
2022-09-300.01B-88.8%0.11B
2022-06-300.05B-5.3%0.10B
2022-03-310.05B0.05B
2021-12-310.00B0.00B
2021-09-300.00B0.00B
2021-06-300.00B0.00B
2021-03-310.00B0.00B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.02B-50.6%
20240.05B+223.4%
20230.01B-86.3%
20220.10B
20210.00B
20200.00B